Therefore, CD103+ DCs are critically dependent on Flt3, and the development of CD103+ DCs is more strongly inhibited in Flt3- and Flt3L-deficient mice than other subsets of DCs [35,78], suggesting Flt3 inhibition can be an option to suppress cDC1s activity in the kidney disease. This evidence concerns the gene ITGAE and kidney disorder.